General Information of Drug (ID: DMI0H3B)

Drug Name
UshStat Drug Info
Synonyms Myosin 7A gene therapy (Usher syndrome 1B, LentiVector), Oxford BioMedica; Myosin VIIA gene therapy (Usher syndrome 1B, LentiVector), Oxford BioMedica
Indication
Disease Entry ICD 11 Status REF
Deafness AB52 Phase 1/2 [1]
Retinitis pigmentosa 9B70 Phase 1 [2]
Cross-matching ID
TTD Drug ID
DMI0H3B

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Myosin-7 (MYH7) TTNIMDP MYH7_HUMAN Modulator [3]

References

1 ClinicalTrials.gov (NCT02065011) A Study to Determine the Long-Term Safety, Tolerability and Biological Activity of UshStat in Patients With Usher Syndrome Type 1B. U.S. National Institutes of Health.
2 Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)
3 EIAV-based retinal gene therapy in the shaker1 mouse model for usher syndrome type 1B: development of UshStat. PLoS One. 2014 Apr 4;9(4):e94272.